Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 9, 2008, Pages 1002-1011

  Dobis, Dave R ^a   Sawyer, Richard T ^a,b   Gillespie, May M ^a   Huang, Jie ^a   Newman, Lee S ^b   Maier, Lisa A ^a,b   Day, Brian J ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Glutathione; N acetylcysteine; Oxidative stress; Reactive oxygen species; T cells

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CYSTEINE; GLUTATHIONE; MANGANESE 5,10,15,20 TETRAKIS(4 BENZOIC ACID)PORPHYRIN; REACTIVE OXYGEN METABOLITE; TETANUS TOXOID; THIOL;

ADULT; ANTIGEN PRESENTING CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BERYLLIOSIS; CD4+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SENSITIZATION; CELL PROLIFERATION; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ADULT; ANTIOXIDANTS; BERYLLIOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHRONIC DISEASE; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 42949118704     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200707-1021OC     Document Type: Article

References (44)

1. Henneberger PK, Goe SK, Miller WE, Doney B, Groce DW. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed. J Occup Environ Hyg 2004;1:648-659.
2. Fontenot AP, Kotzin BL. Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity. Tissue Antigens 2003;62:449-458.
3. Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 2005;171:54-60.
4. Reth M. Hydrogen peroxide as a second messenger in lymphocyte activation. Nat Immunol 2002;3:1129-1134.
5. Hildeman DA, Mitchell T, Kappler J, Marrack PC. T cell apoptosis and reactive oxygen species. J Clin Invest 2003;111:575-581.
6. Day BJ, Fridovich IA, Crapo JD. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch Biochem Biophys 1997;347:256-262.
7. Day BJ, Shawen S, Liochev SI, Crapo JD. A metalloporphyrin superoxide dismutase mimetic protects against Paraquat-induced endothelial cell injury, in vitro. J Pharmacol Exp Ther 1995;275:1227-1232.
8. Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, Kappler J, Marrack PC. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 1999;10:735-744.
9. Sawyer RT, Dobis DR, Goldstein M, Velsor L, Maier LA, Fontenot AP, Silveira L, Newman LS, Day BJ. Beryllium-stimulated reactive oxygen species and macrophage apoptosis. Free Radic Biol Med 2005;38:928-937.
10. Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS. Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol 1991;88:54-60.
11. Sawyer RT, Day BJ, Fadok VA, Chiarappa-Zucca M, Maier LA, Fontenot AP, Sliveira L, Newman LS. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Am J Respir Cell Mol Biol 2004;31:470-477.
12. 3. J Clin Invest 1987;80:381-386.
13. Calhoun WJ, Salisbury SM. Heterogeneity in cell recovery and superoxide production in buoyant, density-defined subpopulations of human alveolar macrophages from healthy volunteers and sarcoidosis patients. J Lab Clin Med 1989;114:682-690.
14. Comhair SA, Lewis MJ, Bhathena PR, Hammel JP, Erzurum SC. Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease. Am J Respir Crit Care Med 1999;159:1824-1829.
15. Sawyer RT, Abraham JA, Daniloff E, Newman LS. Secondary ion mass spectroscopy demonstrates retention of beryllium in chronic beryllium disease granulomas. J Occup Environ Med 2005;47:1218-1226.
16. 1. FASEB J 2000;14:1741-1748.
17. Mahadev K, Zilbering A, Zhu L, Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 2001;276:21938-21942.
18. Touyz RM. Reactive oxygen species and angiotensin II signaling in vascular cells: implications in cardiovascular disease. Braz J Med Biol Res 2004;37:1263-1273.
19. Williams MS, Kwon J. T cell receptor stimulation, reactive oxygen species, and cell signaling. Free Radic Biol Med 2004;37:1144-1151.
20. Williams MS, Henkart PA. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J Immunol 1996;157:2395-2402.
21. Tatla S, Woodhead V, Foreman JC, Chain BM. The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells. Free Radic Biol Med 1999;26:14-24.
22. Kwon J, Devadas S, Williams MS. T cell receptor-stimulated generation of hydrogen peroxide inhibits MEK-ERK activation and Lck serine phosphorylation. Free Radic Biol Med 2003;35:406-417.
23. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 2004;5:818-827.
24. Novogrodsky A, Ravid A, Rubin AL, Stenzel KH. Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc Natl Acad Sci USA 1982;79:1171-1174.
25. Fidelus RK, Ginouves P, Lawrence D, Tsan MF. Modulation of intracellular glutathione concentrations alters lymphocyte activation and proliferation. Exp Cell Res 1987;170:269-275.
26. Fidelus RK, Tsan MF. Enhancement of intracellular glutathione promotes lymphocyte activation by mitogen. Cell Immunol 1986;97:155-163.
27. Chaudhri G, Hunt NH, Clark IA, Ceredig R. Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. Cell Immunol 1988;115:204-213.
28. Dornand J, Gerber M. Inhibition of murine T-cell responses by antioxidants: the targets of lipo-oxygenase pathway inhibitors. Immunology 1989;68:384-391.
29. Forman HJ, Torres M, Fukuto J. Redox signaling. Mol Cell Biochem 2002;49:234-235.
30. Cavelier G. Theory of malignant cell transformation by superoxide fate coupled with cytoskeletal electron-transport and electron-transfer. Med Hypotheses 2000;54:95-98.
31. Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004;337:1-13.
32. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-720.
33. Sawyer RT, Fontenot AP, Barnes TA, Parsons CE, Maier LA, Gillespie MM, Gottschall EB, Hagman JA, Newman LS. Beryllium-induced TNF-α production is transcription-dependent in chronic beryllium disease. Am J Respir Cell Mol Biol 2007;36:191-200.
34. He HT, Lellouch A, Marguet D. Lipid rafts and the initiation of T cell receptor signaling. Semin Immunol 2005;17:23-33.
35. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci USA 1998;95:3071-3076.
36. Staal FT, Anderson MT, Staal GE, Herzenberg LA, Gitler C. Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. Proc Natl Acad Sci USA 1994;91:3619-3622.
37. Staal FT, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor-κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87:9943-9947.
38. Mihm S, Ennen J, Pessara U, Kurth R, Droge W. Inhibition of HIV-1 replication and NF-κB activity by cysteine and cysteine derivatives. AIDS 1991;5:497-503.
39. 2+-mediated endogenous endonuclease activation in apoptotic thymocytes. J Immunol 1995;155:5133-5139.
40. Treitinger A. Effect of N-acetyl-L-cysteine on lymphocyte apoptosis, lymphocyte viability, TNF-α and IL-8 in HIV-infected patients undergoing anti-retroviral treatment. Braz J Infect Dis 2004;8:363-371.
41. Reimund JM. Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1998;28:145-150.
42. Malorni W, Rivaben R, Santini MT, Donelli G. N-Acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells. FEBS Lett 1993;327:75-78.
43. 2, a necessary evil for cell signaling. Science 2006;312:1882-1883.
44. + T cells is mediated by HALDP. Am J Respir Cell Mol Biol 2004;31:122-130.